OTTONELLI, ILARIA
 Distribuzione geografica
Continente #
NA - Nord America 792
EU - Europa 604
AS - Asia 131
SA - Sud America 1
Totale 1.528
Nazione #
US - Stati Uniti d'America 789
IT - Italia 398
GB - Regno Unito 70
HK - Hong Kong 64
SE - Svezia 61
CN - Cina 40
DE - Germania 18
FR - Francia 15
FI - Finlandia 14
BG - Bulgaria 10
MY - Malesia 9
VN - Vietnam 8
ES - Italia 5
BE - Belgio 3
IE - Irlanda 3
PL - Polonia 3
TR - Turchia 3
AN - Antille olandesi 2
GR - Grecia 2
IL - Israele 2
IN - India 2
UA - Ucraina 2
BR - Brasile 1
CA - Canada 1
KR - Corea 1
SG - Singapore 1
TW - Taiwan 1
Totale 1.528
Città #
Chandler 115
Fairfield 109
Ashburn 84
Modena 69
Seattle 63
Hong Kong 62
Woodbridge 59
Nyköping 52
Southend 42
New York 41
Cambridge 39
Houston 37
Wilmington 29
Bologna 23
Reggio Emilia 17
San Diego 17
Beijing 15
Helsinki 12
London 12
Milan 12
Shanghai 12
Princeton 11
Sofia 10
Ann Arbor 9
Parma 9
Dong Ket 8
Rome 8
Falls Church 7
Cagliari 5
Cento 5
Dearborn 5
Naples 5
Vailate 5
Bari 4
Besano 4
Bomporto 4
Como 4
Des Moines 4
Eugene 4
Iesi 4
Padova 4
Turin 4
Baricella 3
Brussels 3
Castelcovati 3
Chicago 3
Dublin 3
Duncan 3
Hounslow 3
Imola 3
Macchiagodena 3
Minneapolis 3
Nanjing 3
Nocera Inferiore 3
Prato 3
Sassuolo 3
Soliera 3
Washington 3
Aberdare 2
Acton 2
Albairate 2
Alicante 2
Angers 2
Castelfranco Emilia 2
Castelnovo 2
Central 2
Chieti 2
Chiswick 2
Cividale del Friuli 2
Ferrara 2
Florence 2
Formigine 2
Izmir 2
Jacksonville 2
Lappeenranta 2
Maranello 2
Munich 2
Norwalk 2
Osio Sopra 2
Piovene Rocchette 2
Poggiomarino 2
Prescot 2
Ramiola 2
Rende 2
San Giuliano Milanese 2
Traversetolo 2
Trento 2
Tusa 2
Verona 2
Viareggio 2
Willemstad 2
Wuhan 2
Athens 1
Belo Horizonte 1
Bitonto 1
Boardman 1
Campegine 1
Campogalliano 1
Carovigno 1
Catania 1
Totale 1.168
Nome #
Targeting Brain Disease in MPSII: Preclinical Evaluation of IDS-Loaded PLGA Nanoparticles 207
Glioblastoma: State of the Art of Treatments and Applications of Polymeric and Lipidic Nanomedicines 165
PLGA-PEG-ANG-2 Nanoparticles for Blood-Brain Barrier Crossing: Proof-of-Concept Study 154
Nanomedicine against Aβ aggregation by β–sheet breaker peptide delivery: In vitro evidence 142
Investigating Novel Syntheses of a Series of Unique Hybrid PLGA-Chitosan Polymers for Potential Therapeutic Delivery Applications 136
Novel peptide-conjugated nanomedicines for brain targeting: In vivo evidence 125
Microfluidic technology for the production of hybrid nanomedicines 94
Insights into kinetics, release, and behavioral effects of brain-targeted hybrid nanoparticles for cholesterol delivery in Huntington's disease 87
Tween® preserves enzyme activity and stability in PLGA nanoparticles 73
Optimization of an Injectable Hydrogel Depot System for the Controlled Release of Retinal-Targeted Hybrid Nanoparticles 59
"Combo" Multi-Target Pharmacological Therapy and New Formulations to Reduce Inflammation and Improve Endogenous Remyelination in Traumatic Spinal Cord Injury 49
Autism-associated SHANK3 mutations impair maturation of neuromuscular junctions and striated muscles 44
Recent Advances on Surface-Modified GBM Targeted Nanoparticles: Targeting Strategies and Surface Characterization 43
Nanotecnologie avanzate per il Sistema Nervoso Centrale: progettazione, ottimizzazione, applicazione, e scale-up 36
Tunneling Nanotubes: A New Target for Nanomedicine? 33
Chronic cholesterol administration to the brain supports complete and long-lasting cognitive and motor amelioration in Huntington's disease 31
Glioblastoma Multiforme Selective Nanomedicines for Improved Anti-Cancer Treatments 29
Nanowired Delivery of Curcumin Attenuates Methamphetamine Neurotoxicity and Elevates Levels of Dopamine and Brain-Derived Neurotrophic Factor 21
Hyaluronic Acid Scaffolds for Loco-Regional Therapy in Nervous System Related Disorders 15
Enzyme Stability in Nanoparticle Preparations Part 1: Bovine Serum Albumin Improves Enzyme Function 12
Quantitative comparison of the protein corona of nanoparticles with different matrices 7
Corrigendum to “Quantitative comparison of the protein corona of nanoparticles with different matrices” [Int J Pharm X 2022 Oct 21;4: 100136] (International Journal of Pharmaceutics: X (2022) 4, (S2590156722000251), (10.1016/j.ijpx.2022.100136)) 3
C-end rule peptide-guided niosomes for prostate cancer cell targeting 2
Totale 1.567
Categoria #
all - tutte 9.803
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.803


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201915 0 0 0 0 0 0 0 0 0 0 4 11
2019/2020123 5 3 4 6 6 7 12 14 12 29 13 12
2020/2021378 35 17 32 42 13 22 57 29 21 39 32 39
2021/2022297 20 2 13 23 34 25 18 17 42 28 37 38
2022/2023349 36 37 22 38 30 33 13 39 34 15 24 28
2023/2024405 24 43 34 41 76 53 31 63 14 26 0 0
Totale 1.567